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Purpose: To assess the diagnostic performance of signal changes in Hoffa’s fat pad (HFP) assessed on non-
contrast-enhanced (CE) magnetic resonance imaging (MRI) in detecting synovitis, and the association of
pain with signal changes in HFP on non-CE MRI and peripatellar synovial thickness on CE MRI.
Methods: The Multicenter Osteoarthritis (MOST) Study is an observational study of individuals who have
or are at high risk for knee OA. All subjects with available non-CE and CE MRIs were included. Signal
changes in HFP were scored from 0 to 3 in two regions using non-CE MRI. Synovial thickness was scored
from 0 to 2 on CE MRI in ﬁve peripatellar regions. Sensitivity, speciﬁcity and accuracy of HFP signal
changes were calculated considering synovial thickness on CE MRI as the reference standard. We used
logistic regression to assess the associations of HFP changes (non-CE MRI) and synovial thickness (CE
MRI) with pain from walking up or down stairs, after adjusting for potential confounders.
Results: A total of 393 subjects were included. Sensitivity of infrapatellar and intercondylar signal changes
in HFP was high (71% and 88%), but speciﬁcity was low (55% and 30%). No signiﬁcant associations were
found between HFP changes on non-CE MRI and pain. Grade 2 synovial thickness assessed on CE MRI was
signiﬁcantly associated with pain after adjustments for potential confounders.
Conclusion: Signal changes in HFP detected on non-CE MRI are a sensitive but non-speciﬁc surrogate for
the assessment of synovitis. CE MRI identiﬁes associations with pain better than non-CE MRI.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Synovitis is an important feature of knee osteoarthritis (OA), and
may manifest directly as thickening of the synovial membrane or
indirectly as joint effusion due to synovial activation1,2. Direct
imaging assessment of synovitis is probably ideally performed
using contrast-enhanced (CE) magnetic resonance imaging
(MRI)1,3e5. Because administration of gadolinium-based contrastM.D. Crema, Department of
rsity School of Medicine, 820
02118, USA. Tel: 1-617-414-
ema).
s Research Society International. Pagents has potential hazardous side effects and is costly, CE MRI is
rarely applied in large epidemiological OA studies or clinical trials.
Assessment of synovitis in knee OA studies is usually performed on
non-CE MRI using signal alterations detected in Hoffa’s fat pad
(HFP) as a synovitis surrogate6e9. In a radiological-pathologic cor-
relation study conducted by Fernandez-Madrid et al., it was shown
that such signal changes correlate with mild chronic synovitis10.
This work led to the assumption that synovitis may be assessed on
non-CE MRI, mainly on fat-suppressed (FS) proton density- or T2-
weighted sequences, using signal alterations in the HFP as a sur-
rogate for whole-knee synovitis. Furthermore, such signal changes
detected in HFP on non-CE MRI have shown clinically relevant
associations in subjects with knee OA6,7,11.
While signal alterations in HFP detected on non-CE MRI
sequences are a sensitive sign of peripatellar synovitis, they areublished by Elsevier Ltd. All rights reserved.
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non-CE and CE MRI12, and present a multitude of possible diag-
noses13. It is important to conﬁrm whether such signal alterations
in HFP truly correspond with synovitis as detected by synovial
thickening and enhancement on CE MRI, as the role of synovitis in
regard to symptoms and progression of disease is still not fully
understood. To our knowledge, the associations of synovitis
assessed on both non-CE and CE MRI with peripatellar pain have
never been evaluated and compared using a large study sample.
The aims of this study were: (1) to evaluate the diagnostic
performance of signal changes in HFP on non-CE MRI for the
detection of synovitis using synovial thickness on CE MRI as the
reference standard; and (2) to assess the associations of signal
changes in HFP (non-CE MRI) and peripatellar synovial thickness
(CE MRI) with pain on walking up or down stairs.
Material and methods
Study design and subjects
Subjects were participants in the Multicenter Osteoarthritis
(MOST) Study, a prospective epidemiological study of 3026 people
aged 50e79 years with a goal of identifying risk factors for incident
and progressive knee OA in a population either with or at high risk
of developing OA. They were recruited from two US communities,
Birmingham, Alabama and Iowa City, Iowa through mass mailing
of letters and study brochures, supplemented by media and
community outreach campaigns. MOST subjects were recruited
and enrolled between June 2003 and March 2005. The Health
Insurance Portability and Accountability Act-compliant study pro-
tocol was approved by the Institutional Review Boards at the Uni-
versity of Iowa, University of Alabama at Birmingham, University of
California San Francisco and Boston University School of Medicine.
We obtained written informed consent from all patients. Subjects
considered at high risk for knee OA included those who were
overweight or obese, those with knee pain, aching or stiffness on
most of the last 30 days, a history of knee injury that made it dif-
ﬁcult to walk for at least 1 week, or previous knee surgery. Subjects
were not eligible to participate inMOST if they screened positive for
rheumatoid arthritis14, had ankylosing spondylitis, psoriatic
arthritis, reactive arthritis, renal insufﬁciency that required hemo-
or peritoneal dialysis, a history of cancer (except for non-melanoma
skin cancer), had or planned to have bilateral knee replacement
surgery, were unable to walk without assistance, or were planning
to move out of the area in the next 3 years.
In the present study, an unselected subset of MOST subjects who
volunteered to undergo CE MRI of one knee at the 30-month
follow-up clinic visit was evaluated. CE MRI scans were obtained
on one knee only. The knee with lower KellgreneLawrence (KL)
grade was selected to avoid choosing knees with severe OA and
decrease the likelihood of co-occurrence of other structural fea-
tures that are potentially associated with pain. If the grade was the
same for both knees, the dominant leg was chosen. The CE MRI was
performed on the same day or within 30 days of non-CE MRI
obtained in all MRI eligible subjects in the parent study (95% of
knees were assessed with CE MRI on the same day as the non-CE
MRI). For persons with renal disease, diabetes or over the age of
65, serum creatinine was determined and the glomerular ﬁltration
rate calculated before intravenous gadolinium administration.
Persons with renal insufﬁciency (glomerular ﬁltration rate<30 ml/
min) were excluded from the present study.
Altogether 1295 subjects were approached at the two clinical
centers (624 at Birmingham and 671 at Iowa City). Of these, 336
participants refused to undergo the 1.5 T CE MRI. Documented
reasons were “unwillingness to receive injection” (n ¼ 121), “notime/too busy” (n ¼ 169) and “other reason” (n ¼ 46). 256 subjects
were excluded because they reported kidney disease, had an ele-
vated serum creatinine level or did not receive a 1.0 T MRI at 30
months. Further, 157 subjects that were approached and scheduled
missed the 30-month visit for other reasons leaving 546 subjects
that were examined with 1.5 T CE MRI. Finally, other 153 were
excluded from the analysis due to incomplete MRI readings for
peripatellar synovitis (CE MRI) and signal changes in HFP (non-CE
MRI), leaving 393 subjects (one knee per subject) included in the
analysis.
Radiographs
At the 30-month follow-up visit, all subjects underwent weight-
bearing postero-anterior (PA) ﬁxed ﬂexion knee radiographs using
the protocol by Kothari et al. and a Plexiglas positioning frame
(SynaFlexer)15. A musculoskeletal radiologist and a rheumatolo-
gist who were not authors, both with over 10 years experience
reading study radiographs and blinded to clinical data, graded the
X-rays independently according to the KL scale16. Radiographs were
presented sequentially with readers blinded to all clinical data and
to MRI. Whole-knee radiographic OA was considered present if KL
grade 2 or patellofemoral OA occurred on lateral view radio-
graphs, which was deﬁned by the presence of a deﬁnite osteophyte
in the patellofemoral joint. If readers disagreed on the presence of
radiographic OA, readings were adjudicated by a panel of three
readers (two non-authors and DTF).
MRI acquisition
For the MOST parent study, MRIs were obtained with a 1.0 T
dedicated extremity unit (ONI MSK Extreme 1.0 T, GE Healthcare,
Wilmington, MA) with a circumferential extremity coil using FS fast
spin-echo proton density-weighted (PDw) sequences in two
planes, sagittal [TR ¼ 4800 ms, TE ¼ 35 ms, 3 mm slice thickness,
0 mm interslice gap, 32 slices, 288  192 matrix, two excitations
(NEX), 140  140 mm ﬁeld of view (FOV), echo train length
(ETL) ¼ 8] and axial (TR ¼ 4680 ms, TE ¼ 13 ms, 3 mm slice
thickness, 0 mm interslice gap, 20 slices, 288  192 matrix, two
NEX, 140  140 mm FOV, ETL ¼ 8), and a short tau inversion-
recovery (STIR) sequence in the coronal plane (TR ¼ 6650 ms,
TE¼ 15 ms, TI ¼ 100 ms, 3 mm slice thickness, 0 mm interslice gap,
28 slices, 256  192 matrix, two NEX, 140  140 mm FOV, ETL ¼ 8).
Additionally, CE MRIs were obtained with a 1.5 T system (Sie-
mens MAGNETOM Symphony, Malvern, PA) with a circum-
ferential extremity coil. Axial and sagittal FS T1-weighted CE
sequences were acquired (TR ¼ 600 ms, TE ¼ 13 ms, 3.0 mm slice
thickness, 0.3 mm interslice gap, 160  160 mm FOV, 512  512
matrix, ETL ¼ 1). Intravenous gadolinium [Magnevist (gado-
pentetate dimeglumine; Bayer HealthCare Pharmaceuticals, Bayer
Schering Pharma AG, Berlin, Germany) or Omniscan (gadodia-
mide; GE Healthcare, New Jersey, USA)] was administered at a dose
of 0.2 ml (0.1 mmol) kg body weight. Twominutes after completing
the injection of the gadolinium, sagittal sequences were obtained
followed immediately by the axial sequences. Two minutes was
chosen to depict optimal synovial enhancement and complete
acquisition of images before relevant diffusion of the contrast agent
into the joint cavity occurred17.
MRI interpretation
MRI readings were performed independently by two muscu-
loskeletal radiologists (AG, FWR), with 9 and 7 years of experience
in semiquantitative MRI assessment of knee OA. Readers were
blinded to radiographic data, as well as to the subjects’ pain status.
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Healthcare, Milwaukee, WI).
On sagittal non-CE MRI PDw FS images, signal alterations in the
infrapatellar and intercondylar regions of HFP were assessed and
semiquantitatively scored from 0 to 3, as a surrogate for synovitis as
previously reported6,7,10. Changes in HFP considered in the present
study represented areas of ill-deﬁned high signal intensity in HFP
seen on sagittal proton-density FS images, which were lining the
synovial membrane in the infrapatellar and intercondylar regions
(Fig. 1). The extent of signal changes was subjectively evaluated
regarding the area of interest of HFP assessed (infrapatellar vs
intercondylar) that is affected by such signal changes, according to
the following scale: 0 (normal), 1 (mild), 2 (moderate), and 3
(severe). The inter-reader reliability (weighted kappa) for the
readings of signal alterations in HFP on non-CE MRI was 0.65.
On CE MRI, synovitis was deﬁned as enhancing thickened syno-
vium (>2 mm). We assessed the synovium in ﬁve peripatellar
regions: the suprapatellar, infrapatellar, and intercondylar regionse
evaluated with sagittal CE MRI; and the medial and lateral para-
patellar regions e evaluated with axial CE MRI images. Synovial
thickness was scored using a whole-joint semiquantitative scoring
system for the assessment of synovitis in CEMRI5: grade 0 if<2mm,
grade 1 if 2e4 mm, and grade 2 if >4 mm, based on the maximal
thickness at each site (Fig. 2). The inter-reader reliability (weighted
kappa) for the readings of synovial thickness on CEMRI varied from
0.67 to 0.83.
On non-CE MRI, we also assessed the presence of bone marrow
lesions (BMLs) in knees using the Whole-Organ Magnetic Reso-
nance Imaging Score (WORMS) scoring system18. BMLs were
assessed in this study since such lesions are associated with knee
pain11,19. BMLs were evaluated in all 15 subregions of the knee as
deﬁned in WORMS, and scored from 0 to 3 based on the extent of
regional involvement: 0 ¼ none; 1 ¼ <25% of the subregion,
2 ¼ 25e50% of the subregion; 3 ¼ >50% of the subregion. BMLs
were considered as “present” when any of the 15 subregions of the
knee had a BML score 1.
Knee pain assessment
The 3.0 Likert version of the Western Ontario and McMaster-
Osteoarthritis Index (WOMAC) was applied at the 30-month clinic
visit. For each of the ﬁve WOMAC pain items subjects rated their
pain from 0 (no pain) to 4 (extreme pain). As we evaluated peri-
patellar synovitis and pain on walking up or down stairs isFig. 1. Sagittal FS PDw (non-CE MRI) shows signal changes in HFP depicted acommonly considered to be present in subjects with patellofemoral
pain syndrome20, we retained only the WOMAC score for pain on
walking up or down stairs in our analyses.
Statistical analyses
To test the diagnostic performance of signal changes depicted in
HFP (infrapatellar and intercondylar regions) on non-CE MRI, we
calculated the sensitivity, speciﬁcity, and accuracy of any signal
change detected on non-CE MRI (grade 1), referring to the
synovial thickness measurements in the infrapatellar and inter-
condylar regions on CE MRI as the reference standard, in which
synovitis was deﬁned as any grade 1. Infrapatellar and inter-
condylar synovitis were analyzed separately.
To assess the cross-sectional associations of signal changes in
HFP depicted on non-CE MRI and abnormal synovial thickening on
CEMRI (the predictors) with pain onwalking up or down stairs (the
outcome), we considered only the maximum score of signal
changes on non-CE MRI (two locations) or synovial thickening on
CE MRI (ﬁve locations). Patients with no signal changes on non-CE
MRI (grade 0) and no abnormal synovial thickening (grade 0) in any
assessed region formed the reference group. The presence of pain
on walking up or down stairs (outcome) was deﬁned as WOMAC
grade 1.
The associations were evaluated using logistic regression,
adjusting for age, gender, body mass index (BMI), whole-knee
radiographic OA, and the presence of BMLs in any of the 15 sub-
regions of the knee (adjusted model). We further examined the
incremental utility of each of the predictors by evaluating dis-
crimination using c-statistic analysis. We further compared c-sta-
tistics using the Chi-square test to evaluate whether values for both
non-CE and CE MRI were signiﬁcantly different. Finally, we inclu-
ded synovitis measurements performed on both non-CE and CE
MRI in the same model to assess their association with pain (fully
adjusted model). All analyses were performed using SAS 9.1 (SAS
Institute, Cary, North Carolina, USA).
Results
A total of 393 subjects (one knee per subject) were included. At
baseline, the mean age (standard deviation) was 58.8  7.0 years,
mean BMI 29.5  4.8, and 46.1% were women. The prevalence of
whole-knee radiographic OA was 26.2%. There were signiﬁcant
differences for the same characteristics when comparing tot the intercondylar (arrows, a) and the infrapatellar (arrows, b) regions.
Fig. 2. Sagittal (a) and axial (b) FS T1-weighted MRIs after intravenous gadolinium injection (CE MRI) demonstrate pathological synovial enhancement and thickening (synovitis)
detected at the suprapatellar (SP), infrapatellar (IP), intercondylar (IC), medial parapatellar (PM), and lateral parapatellar (PL) regions.
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(n ¼ 2633): mean age 63.1  8.1 years (P-value < 0.001), mean BMI
30.9  6.1 (P-value < 0.001), 62.3% women (P-value < 0.001), and
prevalence of whole-knee radiographic OA of 31.7% (P-
value < 0.001).
The prevalence of knee pain on walking up or down stairs was
52.9%. Signal changes (grade 1) in HFP on non-CE MRI were
detected in 312 knees (79.4%). Abnormal synovial thickening (grade
1) in at least one peripatellar region on CE MRI was detected in
200 knees (50.9%). From 393 knees included, 358 were completely
evaluated for the presence of BMLs at 30months (nomissing values
in any of the 15 subregions), and 287 (80.2%) had BMLs in at least
one subregion of the knee. Missing BML data in 35 knees was
mainly due to the presence of susceptibility artifacts in the FOV
affecting at least one of the 15 subregions assessed. The subjects’
characteristics and prevalence of each grade of signal changes and
synovial thickening are presented in Table I.
With CE MRI as the reference standard, the sensitivity of infra-
patellar and intercondylar signal changes in HFP on non-CE MRI
was high (71% and 88%, respectively), but speciﬁcity was low (55%
and 30%, respectively) (Table II).
In the adjusted model, a signiﬁcant association with pain on
walking up and down stairs was demonstrated only when synovitis
was assessed with CE MRI for grade 2 peripatellar synovial thick-
ness [adjusted OR of 4.1; 95% conﬁdence interval (CI) 2.0, 8.1]
(Table III). The assessment of synovitis on CE MRI discriminatedTable I
Characteristics of 393 knees (one knee per subject) used for knee pain analysis.
T1w ¼ T1-weighted
N ¼ 393 knees
Age (year) 58.8 þ 7.0
Women 181 (46.1%)
BMI (kg/m2) 29.5 þ 4.8
Whole-knee radiographic OA 103 (26.2%)
Knees with pain when climbing up or down stairs 208 (52.9%)
Maximal signal change in HFP on PDw FS
Normal (grade 0) 81 (20.6%)
Mild (grade 1) 154 (39.2%)
Moderate (grade 2) 109 (27.7%)
Severe (grade 3) 49 (12.5%)
Maximal synovial thickness on T1w post-gadolinium of ﬁve sites
<2 mm thickness (grade 0) 193 (49.1%)
2e4 mm thickness (grade 1) 118 (30.0%)
>4 mm enhancement (grade 2) 82 (20.9%)pain from non-pain better than the assessment on non-CE MRI (c-
statistics 0.66 vs 0.59 respectively, P-value ¼ 0.03). In the fully
adjusted model in which we included both non-CE and CE syno-
vitis, a signiﬁcant association of synovitis with pain was also found
only when the synovitis was assessed with CE MRI for grade 2
synovial thickness (adjusted OR of 3.2; 95% CI 1.5, 6.7) (Table III). No
signiﬁcant associations were found between signal changes in HFP
assessed using non-CE MRI and pain in both models. The lack of
BML data in 35 knees did not signiﬁcantly affect the results in the
fully adjusted model when considering only the 358 knees com-
pletely evaluated for the presence of BMLs (data not shown).
Discussion
Our study tested the diagnostic performance of signal changes
detected in HFP on non-CE MRI in the detection of peripatellar
synovitis, and demonstrated that such signal changes are sensitive
but not speciﬁc for synovitis (as assessed on CE MRI). In the
adjusted model of our analysis, synovial thickening (grade 2)
assessed using CE MRI showed a signiﬁcant association with peri-
patellar pain, with CE MRI identifying associations with pain better
than non-CE MRI, as demonstrated by a signiﬁcant difference
between both c-statistics values. In the fully adjusted model, only
synovitis assessed on CE MRI showed a signiﬁcant association with
peripatellar pain.
Signal changes in HFP detected on non-CE MRI have been used
as a surrogate for whole-knee synovitis in several clinical and
epidemiologic knee OA studies6e9,11,21, and have demonstrated
associations with knee pain6,7,11. Our study conﬁrmed previous
work by Roemer et al., which showed that, although sensitive,
signal changes in HFP detected on non-CE MRI are not speciﬁc for
synovitis, as represented by thickening and enhancement of the
peripatellar synovium membrane on CE MRI12.The same study also
found that in several cases signal changes in HFP depicted on non-
CE MRI did not enhance at all after intravenous contrast admin-
istration12. Along with our results, we may assume that signal
changes seen in HFP do not always reﬂect peripatellar synovitis;
such changes may reﬂect the late sequelae of active synovial
inﬂammation. Further, such signal changes might represent a
multitude of conditions other than acute or chronic peripatellar
synovitis13.
We also assessed both the associations of signal changes in HFP
(non-CE MRI) and of peripatellar synovial thickening (CE MRI) with
Table II
Sensitivity, speciﬁcity, accuracy of signal changes in HFP on non-CEMRI (PDw FS), considering synovial thicknessmeasurements on CEMRI as the reference standard. TN¼ true
negatives; FN ¼ false negatives; FP ¼ false positives; TP ¼ true positives; Sensitivity ¼ TP/TP þ FN; Speciﬁcity ¼ TN/TN þ FP; Accuracy ¼ TP þ TN/TP þ FP þ FN þ TN
Infrapatellar
Synovial thickness on CE MRI (reference) Signal changes in HFP on non-CE MRI (test) Sensitivity (95% CI) 71% (60%, 81%)
Speciﬁcity (95% CI) 55% (49%, 60%)Grade 0 (normal) Grades 1e3 (abnormal) Total
Grade 0 (normal) 174 (TN) 143 (FP) 317 Accuracy (95% CI) 58% (53%, 63%)
Grade 1 (abnormal) 22 (FN) 54 (TP) 76
Intercondylar
Synovial thickness on CE MRI (reference) Signal changes in HFP on non-CE MRI (test) Sensitivity (95% CI) 88% (79%, 95%)
Speciﬁcity (95% CI) 30% (25%, 35%)Grade 0 (normal) Grades 1e3 (abnormal) Total
Grade 0 (normal) 93 (TN) 222 (FP) 315 Accuracy (95% CI) 41% (36%, 46%)
Grade 1 (abnormal) 9 (FN) 69 (TP) 78
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criteria for knee OA, Loeuille et al. compared non-CE and CE MRIs
for the assessment of synovitis and did not ﬁnd signiﬁcant corre-
lations of any of the two methods (non-CE and CE MRIs) with knee
pain, assessed using the 0e100 pain visual analog scale (VAS)4. In
our study sample, pain was evaluated using the WOMAC ques-
tionnaire, which includes assessment of pain in ﬁve different sit-
uations. Of those ﬁve items, only assessment of pain when walking
up or down stairs is part of the clinical criteria of peripatellar pain
syndrome20. For this reasonwe decided to analyze only this feature
when evaluating the associations of peripatellar signal changes
(non-CE MRI) and synovial thickening (CE MRI) with pain. After
adjusting for age, gender, BMI, whole-knee radiographic OA, and
BMLs (adjusted model) we demonstrated that only grade 2 syno-
vitis assessed using CE MRI was signiﬁcantly associated with pain.
Furthermore, by comparing c-statistics (the area under the ROC
curve), we could demonstrate that synovial thickening detected on
CE MRI discriminates patients with pain from those without pain
better than signal changes depicted on non-CE MRI. After including
the measurements of both non-CE and CE MRI in the model (fully
adjusted model), the association of grade 2 synovial thickening on
CE MRI with pain remained signiﬁcant. In both models, signal
changes in HFP detected using non-CE MRI were not signiﬁcantly
associated with pain. However, the use of a higher threshold of
signal changes in HFP on non-CE MRI might increase not only
speciﬁcity in the detection of synovitis12, but also its association
with knee pain.
There are limitations to our study. First, we compared non-CE vs
CE MRI using different magnetic ﬁeld strengths, and one could
argue that this might lead to bias, especially as the assessment ofTable III
Association between maximum signal change in HFP (PDw FS) and maximum
synovial peripatellar thickness on CE MRI with peripatellar knee pain (WOMAC
score climbing up and down stairs was dichotomized into pain or no pain). *Stat-
istically signiﬁcant deﬁned as P < 0.05
Signal changes on
non-CE MRI in HFP
Number of knees (%) with
pain climbing stairs
Adjusted OR*
(95% CIs)
Adjusted ORy
(95% CIs)
Grade 0 41/81 (51%) 1.0 (reference) 1.0 (reference)
Grade 1 65/154 (42%) 0.6 (0.3, 1.1) 0.6 (0.3, 1.1)
Grade 2 66/109 (61%) 1.4 (0.7, 2.7) 1.2 (0.6, 2.4)
Grade 3 36/49 (74%) 2.2 (0.9, 5.4) 1.3 (0.5, 3.4)
Synovial thickness
on CE MRI
Number of knees (%) with
pain climbing stairs
Adjusted OR*
(95% CIs)
Adjusted ORy
(95% CIs)
Grade 0 78/193 (40%) 1.0 (reference) 1.0 (reference)
Grade 1 65/118 (55%) 1.3 (0.7, 2.2) 1.2 (0.7, 2.1)
Grade 2 65/82 (79%) 4.1 (2.0, 8.1)* 3.2 (1.5, 6.7)*
* Adjusted model (age, sex, BMI, whole-knee radiographic OA, and presence of
BMLs).
y Fully adjusted model (age, sex, BMI, whole-knee radiographic OA, and presence
of BMLs), and measurements of synovitis on both CE and non-CE MRI.signal changes (non-CE) was performed at a lower magnetic ﬁeld
strength (1.0 T) than the CE MRI (1.5 T). Second, no histological
correlation was performed in our study. However, previous studies
on synovitis in rheumatoid arthritis and OA demonstrated that CE
MRI is an accurate tool for the assessment of synovitis1,21,22. Further,
we considered only the presence of pain on walking up or down
stairs for the analyses. Even though the presence of pain onwalking
up or down stairs is described as a feature of the patellofemoral
pain syndrome20, there is no evidence that such pain is associated
only with patellofemoral disease. Also, there is no evidence that the
presence of pain in other situations as assessed using the WOMAC
questionnaire is not associated with patellofemoral disease. Finally,
we did not control for subject selection bias regarding the partic-
ipants who volunteered to undergo CE MRI, and this could poten-
tially affect the homogeneity of subjects included in the present
analysis compared to the whole MOST study sample.
In summary, we conﬁrmed that signal changes in HFP detected
on non-CE MRI are a sensitive but non-speciﬁc surrogate for the
assessment of peripatellar synovitis. Our data suggests that CE MRI
identiﬁes associations of peripatellar synovitis with pain better
than non-CE MRI. Assessment of synovitis should ideally be per-
formed on CE MRI when possible.
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